Related Experiment Video

Updated: Aug 21, 2026

Enhanced Crosslinking Immunoprecipitation (eCLIP) Method for Efficient Identification of Protein-bound RNA in Mouse Testis
10:31

Enhanced Crosslinking Immunoprecipitation (eCLIP) Method for Efficient Identification of Protein-bound RNA in Mouse Testis

Published on: May 10, 2019

The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies

Zhiqing Wang1, Yana Zhang, Arabinda Mandal

  • 1Division of Hematology and Oncology, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|October 12, 2004
PubMed
Abstract

Insights

Sperm protein SLLP1 is a novel cancer-testis antigen found in hematologic malignancies, eliciting immune responses. This finding supports SLLP1 as a potential target for cancer immunotherapy research.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Neoplastic cells frequently exhibit aberrant expression of normal testicular proteins.
  • Proteins with restricted normal tissue expression are potential targets for cancer immunotherapy.
  • Sperm Lysozyme Like Protein 1 (SLLP1) is a recently identified protein in human spermatozoa.

Purpose of the Study:

  • To investigate if SLLP1 functions as a novel cancer-testis antigen in hematologic malignancies.
  • To evaluate the expression of SLLP1 in various hematologic tumors and normal tissues.
  • To determine the immunogenicity of SLLP1 in cancer patients.

Main Methods:

  • SLLP1 expression was assessed using reverse transcription-PCR, real-time PCR, and Western blot analysis.
  • Normal tissue expression was evaluated in healthy donor specimens.
  • Antibody presence against SLLP1 was detected via ELISA.

Main Results:

  • SLLP1 was aberrantly expressed in tumor cells of acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, and multiple myeloma.
  • SLLP1 expression was not detected in normal tissues from healthy donors, only in testis/spermatozoa.
  • High-titer IgG antibodies against SLLP1 were found in sera from some patients with hematologic malignancies.

Conclusions:

  • SLLP1 is identified as a novel cancer-testis antigen in hematologic malignancies.
  • SLLP1 can induce B-cell immune responses in cancer patients.
  • SLLP1 represents a promising target for further in vitro studies to assess its immunotherapy potential.

More Related Videos

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...